NDRA News and Press, ENDRA Life Sciences Inc. From 11/29/21

VGI’s Upcoming Phase 2 NAFLD-NASH study to incorporate ENDRA’s TAEUS technology to help drive trial efficiencies ENDRA Life Sciences Inc. (NASDAQ: NDRA) , a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS ® ), and VGI Health Technol...

ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS ® ), announces that the United States Patent and Trademark Office has issued two patents, including U.S. Patent No. 11172829 (the ‘829 patent) titled “Thermoacoust...

ENDRA Life Sciences, Inc. (NDRA) Q3 2021 Earnings Conference Call November 15, 2021 4:30 PM ET Company Participants Yvonne Briggs – Investor Relations Francois Michelon – Chairman and Chief Executive Officer Renaud Maloberti – Chief Commercial Officer Irina Pestrikova &#x...

Conference call begins at 4:30 p.m. Eastern time today ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS ® ), today reported financial results for the three months ended September 30, 2021 and provided a bus...

ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of enhanced ultrasound technologies, today announced that the company will report financial results for the third quarter of 2021 on Monday, November 15, 2021 after the close of trading on the U.S. financial markets. Managem...

ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS ® ), has recently been issued U.S. Patent 11147067 (the ‘067 patent) titled, “Method And System For Monitoring Tissue Temperature” from the United States Pa...

ENDRA Life Sciences Inc. (NASDAQ: NDRA) , a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS ® ), announces that management will participate in the H.C. Wainwright 5 th Annual NASH Investor Conference on Tuesday, October 12, 2021. Management will deliver a comp...

Gainers: Virpax Pharmaceuticals (NASDAQ:VRPX) +96%, Sesen Bio (NASDAQ:SESN) +28%, Terns Pharmaceuticals (NASDAQ:TERN) +16%, 23andMe (NASDAQ:ME) +16%, NanoVibronix (NASDAQ:NAOV) +9%. Losers: Qualigen Therapeutics (NASDAQ:QLGN) -16%, Sema4 ...

ENDRA Life Sciences, Inc. (NDRA) Q2 2021 Earnings Conference Call August 12, 2021 4:30 PM ET Company Participants Yvonne Briggs – Investor Relations Francois Michelon – Chairman and Chief Executive Officer Renaud Maloberti – Chief Commercial Officer Irina Pestrikova ...

Conference call begins at 4:30 p.m. Eastern time today ANN ARBOR, MI / ACCESSWIRE / August 12, 2021 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS ® ), today reported financial results for the three months ended June 30...